MedTrace Logo

NGS Assessment of Congenitally Deafned Children and Neonatal Deafness Screnning

NCT04350619 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2020-04-17

No results posted yet for this study

Summary

To assess the diagnostic value of NGS screnning in prelingually deafned children using a new designed chip, and to evaluate its interest in a the neonatal screening program for ddetecting congenitally deafned children.

Conditions

  • Congenital Deafness
  • Suspicion of Congenital Deafness

Interventions

OTHER

Genetic screening. No therapeutic intervention

Genetic screening using NGS technique. No therapeutic intervention

Sponsors & Collaborators

  • Instituto de Salud Pública y Laboral de Navarra

    collaborator UNKNOWN

  • Biogipuzkoa Health Research Institute

    collaborator OTHER

  • DREAMgenics S.L.

    collaborator UNKNOWN

  • Hospital CUF Porto, S.A.

    collaborator UNKNOWN

  • Centro Hospitalar de Lisboa Central

    collaborator OTHER

  • University Hospital, Montpellier

    collaborator OTHER

  • University Hospital, Toulouse

    collaborator OTHER

  • Clinica Universidad de Navarra, Universidad de Navarra

    lead OTHER

Principal Investigators

  • Michael Mondain, ENT · University Hospital, Montpellier

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-30
Primary Completion
2020-12-31
Completion
2021-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04350619 on ClinicalTrials.gov